Pharmacogenomics of Arylamine N-acetyltransferase

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|2|3|219-231

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.2, Iss.3, 2004-09, pp. : 219-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Arylamine N-Acetyltransferase 1: A Drug-Metabolizing Enzyme and a Drug Target?

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 759-766

Bentham Science Publishers

Access to resources Recommend Favorite

The first 3D structure of arylamine N-acetyltransferase reveals a protease-like catalytic triad

By Payton M.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 9, 2000-09 ,pp. : 329-330

Elsevier

Access to resources Recommend Favorite

Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts

By Batra Jyotsna   Sharma Surendra K   Ghosh Balaram  

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 673-682

Future Medicine

Access to resources Recommend Favorite

Regulation of the Activity of the Human Drug Metabolizing Enzyme Arylamine N-Acetyltransferase 1: Role of Genetic and Non Genetic Factors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 20, 2004-08 ,pp. : 2519-2524

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin N-acetyltransferase: Mechanism and Inhibition

By  

Current Medicinal Chemistry, Vol. 9, Iss. 12, 2002-06 ,pp. : 1187-1199

Bentham Science Publishers

Access to resources Recommend Favorite